Skip to main content

Advertisement

Log in

Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study

  • Clinical and Epidemiological Study
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Background

The continuing migration of individuals from geographic areas with high/medium endemicity has determined the arrival of new chronic hepatitis B virus (HBV) carriers in Italy. The magnitude of this phenomenon and clinical/virological features of HBsAg-positive migrants remain not very well defined.

Aims

To evaluate the proportion of HBsAg-positive immigrants enrolled in this multicenter Società Italiana di Malattie Infettive e Tropicali (SIMIT) cross-sectional study and to compare the characteristics of chronic hepatitis B infection in migrants to those of Italian carriers.

Methods

From February 1 to July 31 2008, anonymous data were obtained from all HBsAg-positive patients aged ≥18 years observed at 74 Italian centers of infectious diseases.

Results

Of the 3,760 HBsAg-positive subjects enrolled, 932 (24.8 %) were immigrants, with a prevalent distribution in central to northern Italy. The areas of origin were: Far East (37.1 %), Eastern Europe (35.4 %), Sub-Saharan Africa (17.5 %), North Africa (5.5 %), and 4.5 % from various other sites. Compared to Italian carriers, migrants were significantly younger (median age 34 vs. 52 years), predominantly female (57.5 vs. 31 %), and most often at first observation (incident cases 34.2 vs. 13.3 %). HBeAg-positives were more frequent among migrants (27.5 vs. 14 %). Genotype D, found in 87.8 % of Italian carriers, was present in only 40 % of migrants, who were more frequently inactive HBV carriers, with a lower prevalence of chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). Only 27.1 % of migrants received antiviral treatment compared to 50.3 % of Italians.

Conclusions

Twenty-five percent of all HBV carriers examined at Italian centers was composed of immigrants with demographic, serological, and virological characteristics that differed from those of natives and appeared to have an inferior access to treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Stroffolini T, Mele A, Tosti ME, et al. The impact of hepatitis B mass immunization campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol. 2000;33:980–5.

    Google Scholar 

  2. Stroffolini T. The changing pattern of hepatitis B virus infection over the past three decades in Italy. Dig liver Dis. 2005;37:622–627.

    Google Scholar 

  3. Caritas Italiana/Migrantes. Dossier Statistico Immigrazione 2011. XXI Rapporto. Edizioni Idos Roma. http://www.dossierimmigrazione.it/libro.php?cid=47_52&pid=145.

  4. Stroffolini T, Bianco E, Szklo A, et al. Factors affecting the compliance of the antenatal hepatitis B screening programme in Italy. Vaccine. 2003;21:1246–9.

    Article  PubMed  Google Scholar 

  5. Scotto G, Saracino A, Pempinello R, et al.; Gruppo Italiano per lo Studio delle Malattie Infettive negli Immigrati. Epidemiologic multicenter study of the prevalence of hepatitis in hospitalised immigrants in Italy in the year 2002. Ann Ig. 2005;17:11–8.

    PubMed  CAS  Google Scholar 

  6. Da Villa G, Romanò L, Sepe A, et al. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine. 2007;25:3133–6.

    Article  PubMed  Google Scholar 

  7. Spada E, Tosti ME, Zuccaro O, Stroffolini T, Mele A; Collaborating Study Group. Evaluation of the compliance with the protocol for preventing perinatal hepatitis B infection in Italy. J Infect. 2011;62:165–71.

    Article  PubMed  Google Scholar 

  8. Sánchez-Tapias JM, Costa J, Mas A, Bruguera M, Rodés J. Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology. 2002;123:1848–56.

    Article  PubMed  Google Scholar 

  9. Yuen MF, Sablon E, Yuan HJ, et al. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma. Hepatology. 2003;37:562–7.

    Article  PubMed  Google Scholar 

  10. Sumi H, Yokosuka O, Seki N, et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology. 2003;37:19–26.

    Article  PubMed  CAS  Google Scholar 

  11. McMahon BJ. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int. 2009;3:334–42.

    Article  PubMed  Google Scholar 

  12. Cao GW. Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol. 2009;15:5761–9.

    Article  PubMed  CAS  Google Scholar 

  13. Kurbanov F, Tanaka Y, Mizokami M. Geographical and genetic diversity of the human hepatitis B virus. Hepatol Res. 2010;40:14–30.

    Article  PubMed  Google Scholar 

  14. Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol. 2011;26:123–30.

    Article  PubMed  Google Scholar 

  15. Almasio PL, Babudieri S, Barbarini G, et al. Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates). Dig Liver Dis. 2011;43:589–95.

    Article  PubMed  Google Scholar 

  16. Veldhuijzen IK, Toy M, Hahné SJ, et al. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. Gastroenterology. 2010;138:522–30.

    Article  PubMed  Google Scholar 

  17. Stroffolini T, Almasio PL, Sagnelli E, et al. Evolving clinical landscape of chronic hepatitis B: a multicenter Italian study. J Med Virol. 2009;81:1999–2006.

    Article  PubMed  Google Scholar 

  18. Gaeta GB, Stroffolini T, Chiaramonte M, et al. Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology. 2000;32:824–7.

    Article  PubMed  CAS  Google Scholar 

  19. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48:335–52.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are grateful to Ms. Paulene Butts for her assistance in the preparation of the manuscript.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Santantonio.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fasano, M., Saracino, A., Carosi, G. et al. Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study. Infection 41, 53–59 (2013). https://doi.org/10.1007/s15010-012-0384-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-012-0384-9

Keywords

Navigation